cann stock

Ayurcann Launches Online Cannabis Marketplace

Ayurcann Holdings Corp. (CSE: AYUR) (the " Company " or " Ayurcann ") a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative product, is pleased to announce that the company has now launched the Ayurcann Marketplace (" Marketplace "), an online cannabis marketplace for medical cannabis consumers in Canada.

The essence of the Ayurcann Marketplace is to provide Canadian medical cannabis consumers with one of the industries most competitively priced and best selection of high-quality products including vapes, tinctures and topicals. To make this possible, the Company is partnering with various medical cannabis brands and offering their products in a convenient online platform.

In conjunction with the launch of the Ayurcann Marketplace, the company has also made available for purchase, six (6) new products from brands Fuego, and Ayurcann's wholly owned Xplor brand.

The five new products include:

Fuego (Vapes)

  • Cherry Blossom OG
  • La Pardes
  • Vena Grad
  • Wedding Crasher

Xplor (Tinctures)

  • Xplor Pure CBD
  • Xplor Balance

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Canadian medical patients may now register with Ayurcann Marketplace and gain access to a growing catalogue of products. The Company is continuously working on building its catalogue of products offered to patients and is expecting to launch three (3) new brands in the coming weeks.

The goal of the Marketplace is to provide medical cannabis patients with quality products at affordable prices from several producers, all from the comfort of the patient's home. "We saw a gap in the current system and thought there had to be a better option for these patients," stated Igal Sudman, CEO of Ayurcann. Mr. Sudman continued: "We know patients and we know that they prefer to transact digitally, while also being offered a wide range of choice at an exceptional price. With the launch of our Marketplace, we feel that we can fulfill that consumer need and showcase to everyone what differentiates us from our competitors."

The Ayurcann Marketplace will offer the ability for Licensed Producers to apply to have their qualified products listed for sale, where Ayurcann will handle the customer service, online payments, and fulfillment. In instances where manufacturing and packaging is needed, Ayurcann may also be able to provide those functions offering medical cannabis brands and Licenced Producers a seamless solution for selling their products.

Looking to change producer? Register here to become a patient today and receive 20% off your first order¹!

For further information, please contact:
Igal Sudman, Chairman, Chief Executive Officer
Ayurcann Holdings Corp.
Tel: 416-720-6264
Email: igal@Ayurcann.com

Investor Relations:
Ryan Bilodeau
Tel: 416-910-1440
Email: ir@Ayurcann.com

About Ayurcann Holdings Corp.:

Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.

¹ Limited time offer only. Company may end promotion at any time.

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company's expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company's facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company's business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)

Cronos launches leading medical brand PEACE NATURALS® in Germany

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group ("Cansativa"), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

"Re-entering the German market, which has about 83 million people, is a significant milestone for Cronos and we look forward to expanding our reach and brand awareness in Germany with the help of Cansativa," said Mike Gorenstein, Chairman, President, and CEO, Cronos. "We intend to establish our PEACE NATURALS ® brand as a top medical brand, similar to the brand's reputation in Israel. We will continue to push forward on new market growth opportunities and expand our portfolio of borderless products."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Cannabis Dispensary in Pace, Florida

Company celebrates grand opening and expands medical cannabis access to patients in Escambia and Santa Rosa counties

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary located at 5037 Hwy 90, Pace, Fla. The new location will be open 9 a.m. 8:30 p.m. Monday through Saturday and 11 a.m. 8 p.m. on Sundays .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Employee Training Program Earns Multiple Gold Awards for Excellence

Leading cannabis multi-state operator recognized for innovative, best in class human capital management ("HCM") strategy via implementation of its TruU-GROW Employee Training Program

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced its TruU-GROW cultivation training program has received six Gold awards for excellence in the 2023 Brandon Hall Group HCM Excellence Awards™. The awards recognize best practices for initiatives in Learning and Development, Talent Management, Leadership Development, Talent Acquisition, Human Resources, Sales Performance, Diversity, Equity & Inclusion, and the Future of Work. Prior gold medal award winners include leading multinational companies such as Merck & Co., Kraft Heinz, IBM, Chevron, and Deloitte.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces September 2023 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in September.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

  • ATB Capital Markets 2023 Life Sciences Institutional Investor Conference, September 20, 2023 : Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.

  • Benzinga Cannabis Capital Conference, September 27 - 28, 2023 : Founder and CEO Kim Rivers will give a keynote speech on September 27 , Director of Digital Marketing Iram Cesani will participate in a panel discussion on September 27 , and Board Member Susan Thronson will participate in a panel discussion on September 28 .

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-september-2023-event-participation-301920006.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/September2023/07/c0903.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Australia Cannabis Investing: What You Need to Know

Australia Cannabis Investing: What You Need to Know

Since the legalisation of medical cannabis in 2016, Australia has been steadily developing its marijuana industry — and it’s been attracting attention from international players and investors.

With a quickly growing population of over 27 million people and a robust agricultural industry, the country could be positioned to mould itself into a major force in the international cannabis space.

Here, the Investing News Network takes a look at how the cannabis industry in Australia has been shaping up since legalisation, and what these developments could mean for investors. Read on to see what you need to know about investing in cannabis down under.

Keep reading...Show less
Melodiol Global Health Limited

Debt Restructure Update

Melodiol Global Health Limited (ASX:ME1, FRA:1X8) (‘Melodiol’ or ‘the Company’) is pleased to provide the following updates on its agreements with La Plata Capital, LLC (‘La Plata’) which considerably strengthens the Company’s balance sheet ahead of its next phase of growth.

Keep reading...Show less

Latest Press Releases

Related News

×